Katherine Rifiotis Slivensky

Associate

Chicago + 1.312.269.4124

Katherine Rifiotis Slivensky joined Jones Day's New Lawyers Group (NLG) in 2025. The NLG provides new lawyers with the opportunity to explore various practice areas and approaches to law before selecting a specific focus. During their first year, participants may either concentrate on one discipline or rotate among several practices to gain broader experience.

Before attending law school, Katherine worked as a policy analyst at a Department of Energy nuclear physics laboratory and later joined the compliance team of a Fortune 500 financial services firm, where she focused on regulatory strategy and organizational risk management.

Erfahrung

  • BioMarin acquires Amicus Therapeutics for $4.8 billionJones Day is advising BioMarin Pharmaceutical Inc. (Nasdaq: BMRN) in its $4.8 billion acquisition of Amicus Therapeutics (Nasdaq: FOLD).